1.9IRAug 31, 2023
AntM$^{2}$C: A Large Scale Dataset For Multi-Scenario Multi-Modal CTR PredictionZhaoxin Huan, Ke Ding, Ang Li et al.
Click-through rate (CTR) prediction is a crucial issue in recommendation systems. There has been an emergence of various public CTR datasets. However, existing datasets primarily suffer from the following limitations. Firstly, users generally click different types of items from multiple scenarios, and modeling from multiple scenarios can provide a more comprehensive understanding of users. Existing datasets only include data for the same type of items from a single scenario. Secondly, multi-modal features are essential in multi-scenario prediction as they address the issue of inconsistent ID encoding between different scenarios. The existing datasets are based on ID features and lack multi-modal features. Third, a large-scale dataset can provide a more reliable evaluation of models, fully reflecting the performance differences between models. The scale of existing datasets is around 100 million, which is relatively small compared to the real-world CTR prediction. To address these limitations, we propose AntM$^{2}$C, a Multi-Scenario Multi-Modal CTR dataset based on industrial data from Alipay. Specifically, AntM$^{2}$C provides the following advantages: 1) It covers CTR data of 5 different types of items, providing insights into the preferences of users for different items, including advertisements, vouchers, mini-programs, contents, and videos. 2) Apart from ID-based features, AntM$^{2}$C also provides 2 multi-modal features, raw text and image features, which can effectively establish connections between items with different IDs. 3) AntM$^{2}$C provides 1 billion CTR data with 200 features, including 200 million users and 6 million items. It is currently the largest-scale CTR dataset available. Based on AntM$^{2}$C, we construct several typical CTR tasks and provide comparisons with baseline methods. The dataset homepage is available at https://www.atecup.cn/home.
19.0CVMay 9, 2025
Describe Anything in Medical ImagesXi Xiao, Yunbei Zhang, Thanh-Huy Nguyen et al.
Localized image captioning has made significant progress with models like the Describe Anything Model (DAM), which can generate detailed region-specific descriptions without explicit region-text supervision. However, such capabilities have yet to be widely applied to specialized domains like medical imaging, where diagnostic interpretation relies on subtle regional findings rather than global understanding. To mitigate this gap, we propose MedDAM, the first comprehensive framework leveraging large vision-language models for region-specific captioning in medical images. MedDAM employs medical expert-designed prompts tailored to specific imaging modalities and establishes a robust evaluation benchmark comprising a customized assessment protocol, data pre-processing pipeline, and specialized QA template library. This benchmark evaluates both MedDAM and other adaptable large vision-language models, focusing on clinical factuality through attribute-level verification tasks, thereby circumventing the absence of ground-truth region-caption pairs in medical datasets. Extensive experiments on the VinDr-CXR, LIDC-IDRI, and SkinCon datasets demonstrate MedDAM's superiority over leading peers (including GPT-4o, Claude 3.7 Sonnet, LLaMA-3.2 Vision, Qwen2.5-VL, GPT-4Rol, and OMG-LLaVA) in the task, revealing the importance of region-level semantic alignment in medical image understanding and establishing MedDAM as a promising foundation for clinical vision-language integration.
1.2PLASM-PHSep 16, 2025
FusionMAE: large-scale pretrained model to optimize and simplify diagnostic and control of fusion plasmaZongyu Yang, Zhenghao Yang, Wenjing Tian et al.
In magnetically confined fusion device, the complex, multiscale, and nonlinear dynamics of plasmas necessitate the integration of extensive diagnostic systems to effectively monitor and control plasma behaviour. The complexity and uncertainty arising from these extensive systems and their tangled interrelations has long posed a significant obstacle to the acceleration of fusion energy development. In this work, a large-scale model, fusion masked auto-encoder (FusionMAE) is pre-trained to compress the information from 88 diagnostic signals into a concrete embedding, to provide a unified interface between diagnostic systems and control actuators. Two mechanisms are proposed to ensure a meaningful embedding: compression-reduction and missing-signal reconstruction. Upon completion of pre-training, the model acquires the capability for 'virtual backup diagnosis', enabling the inference of missing diagnostic data with 96.7% reliability. Furthermore, the model demonstrates three emergent capabilities: automatic data analysis, universal control-diagnosis interface, and enhancement of control performance on multiple tasks. This work pioneers large-scale AI model integration in fusion energy, demonstrating how pre-trained embeddings can simplify the system interface, reducing necessary diagnostic systems and optimize operation performance for future fusion reactors.
A Multi-View Ensemble Classification Model for Clinically Actionable Genetic MutationsXi Sheryl Zhang, Dandi Chen, Yongjun Zhu et al.
This paper presents details of our winning solutions to the task IV of NIPS 2017 Competition Track entitled Classifying Clinically Actionable Genetic Mutations. The machine learning task aims to classify genetic mutations based on text evidence from clinical literature with promising performance. We develop a novel multi-view machine learning framework with ensemble classification models to solve the problem. During the Challenge, feature combinations derived from three views including document view, entity text view, and entity name view, which complements each other, are comprehensively explored. As the final solution, we submitted an ensemble of nine basic gradient boosting models which shows the best performance in the evaluation. The approach scores 0.5506 and 0.6694 in terms of logarithmic loss on a fixed split in stage-1 testing phase and 5-fold cross validation respectively, which also makes us ranked as a top-1 team out of more than 1,300 solutions in NIPS 2017 Competition Track IV.